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Abstract The aim of the study was to compare the
spontaneous and ex vivo radiation-induced chromosomal
damage in lymphocytes of untreated prostate cancer
patients and age-matched healthy donors, and to evaluate
the chromosomal damage, induced by radiotherapy, and its
persistence. Blood samples from 102 prostate cancer
patients were obtained before radiotherapy to investigate
the excess acentric fragments and dicentric chromosomes.
In addition, in a subgroup of ten patients, simple exchanges
in chromosomes 2 and 4 were evaluated by ﬂuorescent in
situ hybridization (FISH), before the onset of therapy, in
the middle and at the end of therapy, and 1 year later. Data
were compared to blood samples from ten age-matched
healthy donors. We found that spontaneous yields of
acentric chromosome fragments and simple exchanges
were signiﬁcantly increased in lymphocytes of patients
before onset of therapy, indicating chromosomal instability
in these patients. Ex vivo radiation-induced aberrations
were not signiﬁcantly increased, indicating proﬁcient repair
of radiation-induced DNA double-strand breaks in lym-
phocytes of these patients. As expected, the yields of
dicentric and acentric chromosomes, and the partial yields
of simple exchanges, were increased after the onset of
therapy. Surprisingly, yields after 1 year were comparable
to those directly after radiotherapy, indicating persistence
of chromosomal instability over this time. Our results
indicate that prostate cancer patients are characterized by
increased spontaneous chromosomal instability. This
instability seems to result from defects other than a deﬁ-
cient repair of radiation-induced DNA double-strand
breaks. Radiotherapy-induced chromosomal damage per-
sists 1 year after treatment.
Introduction
Prostate cancer is the most frequent malignancy in US and
European men, with increasing rates of incidence. Despite
numerous studies, which identiﬁed many potential risk
factors and suggested many hypotheses on the cause of
prostate cancer, its aetiology remains unknown. Recent
scientiﬁc and clinical evidence suggested an interplay of
genetic susceptibility, predisposition to infection and
impaired antioxidant defence in the genesis of prostate
cancer (Klein et al. 2006).
It is widely accepted that cancer develops through the
accumulation of genetic alterations in a variety of genes
that are essential for cellular processes such as growth,
proliferation, differentiation or programmed cell death,
cellular repair and oxidative stress defence (Kim et al.
2006; Klein et al. 2006; Sandberg 1991; Trzeciak et al.
2004). Repair defects as well as defects in enzymatic
antioxidative defence and/or repair of oxidative DNA
damage may be related to chromosomal changes and may
thus be revealed by cytogenetic means (Dayal et al. 2008;
Solomon et al. 1991; Waters et al. 2007; Wright 1999). The
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DOI 10.1007/s00411-009-0244-xmost noticeable correlation between the presence of high
level genomic/chromosomal instability and a predisposi-
tion to cancer has been established in rare cancer syn-
dromes, namely in ataxia telangiectasia, Bloom’s
syndrome and Fanconi’s anaemia. Low-level genomic
instability is, however, present in peripheral blood lym-
phocytes of patients with a variety of cancer types, such as
breast, skin, stomach, head and neck, and bladder cancers,
testicular seminoma and lymphoma (Barrios et al. 1988,
1990; Bhatti et al. 2008a; Bonassi et al. 1995, 2008; Col-
leu-Durel et al. 2004; De Ruyck et al. 2008; Hagmar et al.
1994, 1998; Madhavi et al. 1990; Nordenson et al. 1984;
Rossner et al. 2005; Schabath et al. 2003; Schmidberger
et al. 2001; Sigurdson et al. 2005; Smith et al. 2003).
Prostate cancer is a multifactor disease, the development
of which involves genomic instability. Although there are
numerous reports in literature on prostate cancer, there is
little information regarding the spontaneous background
levels of chromosomal alterations in these patients (De
Ruyck et al. 2008; Dotan et al. 2004; El-Zein et al. 2005;
Ozen et al. 2000; Steiner et al. 2002; Varga et al. 2005;
Verhagen et al. 2002; Wolter et al. 2002). Varga et al.
reported that spontaneous, as well as radiation-induced,
micronuclei were not increased in sporadic prostate cancer
patients compared to healthy male controls. Interestingly,
they also analysed the frequently postulated age depen-
dence of spontaneous aberration frequencies and found no
differences, within the patient group (22 patients, 54–
75 years old) as well as in the control group (43 men, 26–
77 years old) (Varga et al. 2005).
On the other hand, an increased frequency of chromo-
some aberrations in circulating lymphocytes is often con-
sidered indicative of increased cancer risk after exposure to
DNA-damaging agents, such as irradiation (Barrios et al.
1991; Bonassi et al. 2000; El-Zein et al. 2005; Hagmar
et al. 1998; Heng et al. 2006; Hsu 1983; Kolusayin Ozar
and Orta 2005; Lockett et al. 2006; Scott et al. 1999;
Tzancheva and Komitowski 1997).
To address both issues, spontaneous and radiation-
inducible chromosomal instability, we conducted a study,
including 102 patients with prostate cancer. We investi-
gated whether these patients exhibited increased sponta-
neous chromosomal instability, and/or increased sensitivity
against ionizing radiation, which could account for their
susceptibility to cancer.
Patients, materials and methods
Patients
The present study was based on the analysis of chromo-
some aberrations observed in peripheral blood lymphocytes
obtained from untreated and radiotherapy-treated prostate
cancer patients and healthy donors.
During the ﬁrst part of this study, 102 patients with
previously untreated prostate cancer, registered at the
Department of Radiotherapy and Radiooncology, Univer-
sity Medicine of Go ¨ttingen, participated in this study. Their
tumours were classiﬁed according to the TNM system and
only patients with primary tumours classiﬁed as T1–T3,
N0–N1 and M0 were included in the study. Their median
age was 69 years, and this group contained 66 lifelong non-
smokers, i.e. 72%. For comparison, ten healthy male
donors with matched ages participated in this part of the
study. Their median age was 67 years, and this control
group contained eight non-smokers, i.e. 80%.
During the second part of this study, ten randomly
chosen patients from the study group were included in the
follow-up study. These patients were 62–79 years old, with
a median age of 73 years; all patients were non-smokers.
These patients were followed up during and after the
therapy. Blood samples from these patients were obtained
during therapy, at the end of therapy and 1 year after
therapy (see also Table 1).
The Ethics Committee of the Medical Faculty, Univer-
sity of Go ¨ttingen, approved the study. All patients and
healthy donors provided their informed consent before
participating in the study.
Lymphocyte cultures
Heparinized peripheral blood samples were obtained by
venipuncture from healthy donors and from untreated
patients before therapy and from ten patients during ther-
apy (after 50% of the dose fractions), immediately after
and 1 year after therapy. Unirradiated or ex vivo irradiated
whole blood lymphocytes (1 ml per culture) were cultured
in 9 ml RPMI containing 10% foetal calf serum, 100 ll/ml
PHA (Biochrom, Karlsruhe, Germany) and antibiotics (10
4
I.E./ml penicillin and 10 mg/ml streptomycin) in 5% CO2
atmosphere at 37C. To take into account individual vari-
ability and radiation-induced mitotic delay, all blood
samples were divided and cultured for 46, 48 and 50 h,
respectively. Colcemid (20 ll/ml medium) was added
during the last two culture hours. Metaphase cells were
prepared according to the standard method (hypotonic
0.56 M KCl treatment followed by ﬁxation in methanol
plus glacial acetic acid, 3:1) and stored at 4C.
The optimal culture time for cell preparations con-
taining no more than 6% of cells in their second post-
irradiation mitosis was chosen according to the results
of foregoing evaluation based on FPG staining. This
Giemsa-/Hoechst 33258-staining method allowed for
differentiation between ﬁrst and second post-irradiation
metaphases.
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123Slides for evaluation of dicentric and acentric chromo-
somes were stained with 3% Giemsa solution (ﬁrst part of
this study). In unirradiated or irradiated lymphocytes, 100–
300 cells were scored per patient and healthy donor.
Slides for ﬂuorescent in situ hybridization (FISH) were
prepared and hybridized according to the MetaSystems
protocol (MetaSystems, Altlussheim, Germany). Whole
chromosome probes for chromosomes nos. 2 and 4 (dual
paint FISH) were used simultaneously. Metaphase chro-
mosomes were analysed with a ﬂuorescent microscope
(Zeiss Axioscop, Go ¨ttingen, Germany) equipped with a
triple band pass ﬁlter for DAPI, Texas red and FITC, as
well as with a CCD camera (Visitron Systems GmbH,
Puchheim, Germany). MetaMorphR (West Chester, USA)
software was used for image analysis. Complete and
incomplete reciprocal translocations, dicentric chromo-
somes and complex exchanges involving either of the
painted chromosomes were scored. The yields of dicentric
chromosomes and reciprocal translocations were added up
and classiﬁed as simple exchanges. For each patient and
time (before, during and after therapy) and for each healthy
donor, 250–950 cells were scored.
Ex vivo irradiation
Whole blood samples were irradiated at room temperature
with 200 kV X-rays and a dose of D = 3 Gy. The radiation
from an X-ray tube (Siemens Stabilipan, Erlangen, Ger-
many) was ﬁltered with 0.5 mm of Cu.
Patient irradiation
All patients were treated in the primary treatment setting.
Depending on tumour stage and risk factors (PSA[20 ng/
ml, Gleason-score[7 or positive lymph nodes), the pros-
tate or the prostate and the pelvic nodes were treated. The
dose administered was 71–72 Gy to the prostate and 45 Gy
to the pelvis. The irradiation technique included individual
optimization with conformal treatment planning, the use of
multiple radiation ﬁelds, individual blocks, rectal balloons
or (if possible) the prone position with a belly board, to
reduce the small bowel volume within the planned target
volume. External beam radiotherapy was given using a 20-
MV accelerator (Varian, Palo Alto, USA). Each ﬁeld was
irradiated daily, ﬁve times per week. The dose was speci-
ﬁed according to the ICRU 50 recommendations (ICRU
1993). The exact radiotherapy technique has been descri-
bed previously (Hille et al. 2005, 2008). Table 1 lists the
individual characteristics of the ten patients, who were
followed up during and after radiotherapy.
Statistical analysis
The overall aberration yields scored in lymphocytes from
patients and healthy donors followed Poisson distribution
as analysed by the test introduced by Brown and Zhao
(2002). Therefore, the overall aberration yields in the
patient group and in the healthy donors group were com-
pared as two means of Poisson distributions using Stu-
dent’s t test for inﬁnite degrees of freedom, including the
Yates correction factor. The groups comparing individual
values were also tested by Wilcoxon and Mann and
Whitney U test, and completed by Siegel and Tukey rank
dispersion test. Aberration yields in lymphocytes from
patients before therapy and 1 year after the end of therapy
were tested with these distribution-independent tests. P
values of B0.1 were considered to be signiﬁcant; the exact
P values are indicated in the text.
Results
The aberration yields in lymphocytes of 102 untreated
prostate cancer patients were analysed in Giemsa-stained
Table 1 Characteristics of ten healthy donors and ten study patients with prostate carcinoma followed during and after radiotherapy
Healthy donors Patients
Number Age (years) Number Age (years) Tumour stage Percentage of irradiated
bone marrow volume
1 65 1 75 T2b N1 M0 35
2 69 2 79 T1c N0 M0 17
3 65 3 69 T1c N0 M0 17
4 64 4 76 T1c N0 M0 17
5 65 5 72 T2c N0 M0 17
6 65 6 71 T1c N0 M0 17
7 70 7 77 T2c N0 M0 17
8 81 8 66 T2a N0 M0 17
9 82 9 62 T3a pN1 M0 35
10 92 10 79 T2b N0 M0 35
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123metaphase cells. For comparison, aberration yields of ten
age-matched healthy donors were analysed, as well. In the
patient and control groups, 12,120 and 2,200 cells were
scored, respectively. Aberration yields per cell were cal-
culated for dicentric chromosomes (ydic) and for excess
acentric fragments (yac (ex)). Data are presented in Fig. 1a,
b as individual values, depending on age, and as box plots,
with each box enclosing 50% of all collected data. The
median values are displayed as horizontal lines within the
corresponding boxes. Using Student’s t test for comparison
of two means of Poisson distributions, we found that the
yields of dicentric chromosomes per cell in patients and
healthy donors were not signiﬁcantly different (P = 0.4).
The yields of excess acentric fragments were signiﬁcantly
different in these two groups (P = 0.05), with increased
rates in the patient group. To determine whether aberration
yields were affected by extension of the disease, we also
compared patients with prostate only or with prostate and
nodal disease. Using Student’s t test as described above, we
found no signiﬁcant differences (P = 0.4) between patients
with prostate only or with prostate and nodal disease.
Individual data are shown in Fig. 1a.
Next, we analysed aberration yields in Giemsa-stained
lymphocytes from the same 102 untreated patients and
healthy donors irradiated ex vivo with 200 kV X-rays and a
dose D = 3 Gy. In the patient and control groups, 16,000
and 2,600 cells, respectively, were scored in Giemsa-
stained metaphases. These data are presented in Fig. 2 as
box plots, each box enclosing 50% of all collected data.
The median values are displayed as horizontal lines within
the corresponding boxes. Using Student’s t test for com-
parison of two means of Poisson distributions, we found
that the yields of dicentric chromosomes per cell and those
of excess acentric fragments per cell, as compared in
patients and healthy donors, were not signiﬁcantly differ-
ent. Thus, in the studied prostate cancer patients, only
spontaneous chromosomal instability could be revealed.
Radiation-induced chromosomal instability, which would
indicate an impaired repair of DNA double-strand breaks,
was not observed.
To further analyse the spontaneous chromosomal insta-
bility found in prostate cancer patients, we applied dual-
colour FISH method to lymphocytes and evaluated yields
of simple exchanges (ySE) in 10 out of 102 untreated
patients and in the above 10 healthy donors. In these ten
patients, we also studied the amplitude and persistence of
aberrations as they were induced by conformal radiother-
apy. In this smaller patient group, we analysed Giemsa-
stained as well as FISH-stained lymphocyte metaphases.
Spontaneous and radiation-induced (D = 3 Gy) yields of
simple exchanges in untreated patients and healthy donors,
as well as the yields in patients during, immediately after
Fig. 1 a Spontaneous yields of excess acentric fragments per 100
cells (peripheral lymphocytes) in prostate cancer patients compared to
healthy donors. Prostate cancers patients are divided into patients with
prostate only (open circles) and patients with prostate and nodal
disease (open triangles). Yields of excess acentric fragments (yac (ex))
were determined in Giemsa-stained metaphases. Data are presented as
individual data points plotted depending on age (open sym-
bols = patients; closed diamonds = healthy donors). b Spontaneous
yields of chromosome aberrations per cell (peripheral lymphocytes)
in prostate cancer patients compared to healthy donors. Yields of
dicentric chromosomes (ydic) and excess acentric fragments (yac (ex))
were determined in Giemsa-stained metaphases. Yields of simple
exchanges (ySE), representing sums of dicentric chromosomes and
reciprocal translocations, were evaluated in metaphases with painted
chromosomes 2 and 4. Data are presented as box plots with each box
enclosing 50% of the overall data. The corresponding median value of
the variable is displayed as a horizontal line. The top and the bottom
of the box mark the limits of ±25% of the variable population. The
vertical lines extending from the top and bottom of each box denote
the minimum and maximum values within the data set that are located
within an acceptable range (points with values either greater than the
upper quartile ?1.5x interquartile distance or less than lower quartile
-1.5x interquartile distance); outliers that are not included are
represented by circles
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123and 1 year after therapy were scored in metaphase cells.
Spontaneous and radiation-induced yields of simple
exchanges observed in chromosomes 2 and 4 are included
in Figs. 1b and 2, respectively. Using Student’s t test for
comparison of two means of Poisson distributions, we
found that the yields of spontaneous simple exchanges in
lymphocytes from untreated patients were signiﬁcantly
higher in comparison to healthy donors (P = 0.10). Again,
in agreement with Giemsa-analysis, no signiﬁcant differ-
ence (P = 0.70) was observed in lymphocytes irradiated ex
vivo with D = 3 Gy, as evaluated in the patient and control
groups.
Both Giemsa and FISH results, when compared in
prostate cancer patients and healthy donors, indicate that in
these patients, the spontaneous, but not the radiation-
induced, frequencies of simple exchanges (reciprocal
translocations actually since dicentric yields were not dif-
ferent in both groups) and of excess acentric fragments are
signiﬁcantly increased. The increased spontaneous aberra-
tion frequencies are thus likely to arise from primary DNA
damage that is different from DNA double-strand breaks,
otherwise signiﬁcant differences were observed between
radiation-induced aberration frequencies too. Each one of
the ten patients included in the FISH analysis showed
increased spontaneous yields of simple exchanges per cell
when compared with healthy donors. The corresponding
single data are shown in Table 2.
During the follow-up of the patient subgroup, which
displayed an increased spontaneous rate of chromosomal
aberrations, blood samples were obtained during the ther-
apy (after 50% of the fractions), immediately after and
1 year after therapy. Aberration yields were scored in
Giemsa-stained and FISH-stained metaphases. Summa-
rized data of this follow-up, i.e. yields of dicentrics, yields
of excess acentric fragments and of simple exchanges are
shown in Table 3. Using Giemsa-stain, 100–400 metaphase
cells were scored for each point. For FISH-analysis, 200–
960 cells were scored for each point.
Time dependence of the aberration yields is shown in
Fig. 3a–c, where the data are presented as box plots, each
box enclosing 50% of all data. The median values are
displayed as horizontal lines within the corresponding
boxes. As can be seen in Fig. 3a–c, all types of aberrations
persisted during the ﬁrst year after the end of therapy. The
yields observed immediately after the end of therapy were
not signiﬁcantly different from the yields observed 1 year
after therapy (Wilcoxon, Mann and Whitney U test, com-
pleted by Siegel and Tukey rank dispersion test, P = 0.05).
Discussion
Mechanistic evidence supporting the role of chromosomal
alterations in the development of cancer has been available
for a long time, and epidemiological data showed that
various markers of DNA repair (Berwick and Vineis 2000)
or especially the frequency of chromosomal aberrations in
Fig. 2 Chromosome aberration yields per cell (peripheral lympho-
cytes) in prostate cancer patients compared to healthy donors after ex
vivo irradiation with D = 3 Gy. Blood samples of cancer patients
were taken before radiotherapy. Yields of dicentric chromosomes
(ydic) and excess acentric fragments (yac (ex)) were determined in
Giemsa-stained metaphases. Yields of simple exchanges (ySE),
representing sums of dicentric chromosomes and reciprocal translo-
cations were evaluated in metaphases with painted chromosomes 2
and 4. Data are presented as box plots with each box enclosing 50% of
the overall data. Median value of the variable is displayed as a
horizontal line. The top and the bottom of the box mark the limits of
±25% of the variable population. The lines extending from the top
and bottom of each box denote the minimum and maximum values
within the data set that are located within an acceptable range (points
with values either greater than the upper quartile ?1.5x interquartile
distance or less than lower quartile -1.5x interquartile distance);
outliers that are not included are represented by circles
Table 2 Simple exchanges per cell in chromosomes nos. 2 and 4 in
lymphocytes from prostate cancer patients and age-matched healthy
donors
Healthy donors Patients
Number Ny SE per cell Number Ny SE per cell
1 851 0.007 1 582 0.024
2 959 0.011 2 618 0.034
3 963 0.008 3 541 0.019
4 966 0.005 4 508 0.016
5 264 0.008 5 805 0.022
6 284 0.007 6 733 0.021
7 527 0.009 7 873 0.026
8 487 0.006 8 869 0.026
9 552 0.002 9 844 0.026
10 242 0.000 10 809 0.026
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123peripheral lymphocytes might be an independent marker of
cancer susceptibility (Bonassi et al. 2008).
In the present study, we analysed spontaneous and
radiation-induced chromosomal aberrations in 102 patients
with prostate cancer by Giemsa-staining and in a subgroup
of 10 patients by the FISH technique. In Giemsa-stained
metaphases, genomic yields of dicentric chromosomes and
excess acentric fragments were evaluated separately. Whilst
the spontaneous rate of dicentric chromosomes did not vary
between the studied prostate cancer patients and healthy
subjects, the rate of spontaneous excess acentric fragments
was signiﬁcantly increased in the patient group. This ﬁnding
is similar to the results reported for breast cancer (e.g.
Baeyens et al. 2002; Varga et al. 2006). Of course, it must
be taken into account, that our age-matched healthy donor
group was much smaller than the patient group. It is a
problem to obtain many healthy donors at this age with
normal PSA values. For the same reason, the smoking status
was different between the patient and the control group. The
inﬂuence of smoking on the yields of chromosomal aber-
rations in blood lymphocytes is controversially discussed;
in our study; we found no signiﬁcant differences between
the smoker and the non-smoker groups (P B 0.05). Overall,
our healthy control group was well age-matched and,
therefore, our data indicate that a subgroup of prostate
cancer patients with signiﬁcantly increased chromosomal
instability might exist. Further studies involving a larger
healthy donor group are necessary.
Partial yields of simple exchanges were evaluated by
means of whole chromosome painting involving chromo-
somes nos. 2 and 4. Their spontaneous rates were signiﬁ-
cantly increased in ten patients, as well. These results are
similar to data published by El-Zein et al. (2005), who also
examined spontaneous chromosome instability in prostate
cancer patients and healthy controls. They used short-term
lymphocyte cultures and evaluated chromosomal instabil-
ity using ﬂuorescence in situ hybridization assay with two
probes targeting speciﬁc regions on chromosome X and
chromosome 1. For both chromosomes, their results
showed a signiﬁcantly higher mean level of spontaneous
breaks indicating that spontaneous chromosome instability
could be a risk factor for prostate cancer.
In contrast, Lockett et al. (2006), using the alkaline
Comet assay to evaluate whether basal DNA damage was
associated with prostate cancer risk, found no differences
between cases and controls. The difference in the results of
the study by El-Zein et al. the present study and the study
of Lockett et al. may be due to differences in the applied
methods and the analysed end points.
With respect to radiation-induced chromosomal aberra-
tions, in the present study we found no differences between
patients and healthy subjects. Genomic yields of dicentric
chromosomes and excess acentric fragments, and partial
yields of simple exchanges involving chromosomes nos. 2
and 4 (ten patients) were analysed in blood samples taken
before cancer treatment and irradiated with a dose of 3 Gy
ex vivo. This is in contrast to studies analysing blood
samples of patients with other tumour types, including
breast, colon (Baria et al. 2001) and head-and-neck cancer
(De Ruyck et al. 2008). The relationship between increased
rates of radiation-induced chromosome aberrations in
peripheral lymphocytes and a predisposition to cancer is
based on the assumption that any deﬁciencies in the DNA
repair system maintaining the integrity of the genome are
likely to enable the development of cancer. Depending on
the type of the induced lesion, different repair mechanisms
will be activated. DNA double-strand breaks are a hallmark
of ionizing radiation effects, which will activate speciﬁc
repair pathways, mainly homologous recombination and
nonhomologous end joining. Since we found no increased
Table 3 Aberration yields ydic, yac (ex) and ySE scored before, in the middle and at the end of therapy and 1 year after therapy in lymphocytes
from ten prostate cancer patients who received conformal radiotherapy
Patient number Before therapy Middle of therapy End of therapy 1 year after therapy
ydic yac(ex) ySE ydic yac(ex) ySE ydic yac(ex) ySE ydic yac(ex) ySE
1 0.010 0 0.024 0.170 0.160 0.020 0.220 0.120 0.031 0.172 0.102 0.100
2 0 0.010 0.034 0.290 0.120 0.049 0.440 0.290 0.071 0.143 0.143 0.084
3 0.020 0.029 0.019 0.063 0.089 0.041 0.054 0.080 0.069 0.070 0.078 0.041
4 0.010 0.019 0.016 0.070 0.070 0.010 0.144 0.098 0.051 0.098 0.098 0.060
5 0.010 0.020 0.022 0.140 0.140 0.021 0.260 0.180 0.041 0.149 0.089 0.041
6 0.020 0.048 0.021 0.090 0.050 0.011 0.090 0.070 0.020 0.070 0.070 0.022
7 0.010 0.050 0.026 0.150 0.100 0.009 0.091 0.100 0.042 n.m. n.m. n.m.
8 0 0.018 0.026 0.055 0.082 0.010 0.075 0.103 0.050 0.088 0.072 0.021
9 0.010 0.020 0.026 0.098 0.083 0.019 0.070 0.100 0.031 0.069 0.088 0.019
10 0 0.010 0.026 0.160 0.110 0.039 0.250 0.160 0.078 0.170 0.170 0.099
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123rates of radiation-induced chromosomal aberrations in
patients with prostate cancer, defects in DNA double-
strand break repair pathways might not to be expected for
these patients. Of course, this observation should be con-
ﬁrmed in studies involving a larger healthy donor group.
Increased production of reactive oxygen species, as
often observed in cancer cells (Jackson and Loeb 2001)i n
association with an impaired cellular antioxidative defence
(Nohmi et al. 2005; Trzeciak et al. 2004), will result in
oxidative stress. Increased oxidative stress might promote
tumour development as well (Dayal et al. 2008; Kim et al.
2006; Laurent et al. 2005; Rozalski et al. 2002; Tulard et al.
2003). In particular, the association between prostate can-
cer risk and an increased oxidative stress is widely
accepted (Frohlich et al. 2008; Klein et al. 2006).
In the present study, we found that only spontaneous
rates of excess acentric fragments and simple transloca-
tions (in ten patients) were signiﬁcantly increased in
patients with prostate cancer. In contrast to dicentric
chromosomes and translocations, which typically arise
from radiation-induced double-strand breaks, acentric
fragments, detected also as micronuclei, may be generated
by reactive oxygen species via oxidative base damage
(Mateuca et al. 2008). Micronuclei contain predominantly
acentric chromosomes or chromatid fragments. Increased
spontaneous frequency of micronuclei in lymphocytes of
untreated cancer patients has been already reported (Fen-
ech 2002; Iarmarcovai et al. 2008).
The most frequent oxidative DNA damage is that in the
7, 8- dihydro-8-oxoguanine (8-OHdG) DNA adduct. This
lesion is removed mainly by human oxoguanine glycosy-
lase1, hOGG1, a glycosylase belonging to the group of
prostate cancer susceptibility genes (Klein et al. 2006). In
patients suffering from bone metastasis of their primary
Fig. 3 a–c Genomic yields of excess acentric fragments (a), dicentric
chromosomes (b), and partial yields of simple exchanges (c) per cell
as observed at different times in peripheral lymphocytes of prostate
cancer patients. Genomic aberration yields were determined in
Giemsa-stained metaphases; partial yields of simple exchanges
(dicentric chromosomes plus reciprocal translocations) were evalu-
ated in metaphases with painted chromosomes 2 and 4. Blood samples
of cancer patients were obtained before radiotherapy, in the middle
and at the end of the treatment, as well as 1 year after treatment.
Blood samples, obtained before treatment, were irradiated ex vivo
with D = 3 Gy. Data are presented as box plots with each box
enclosing 50% of the data, and the median value of the variable
displayed as a horizontal line. The top and the bottom of the box mark
the limits of ±25% of the variable population. The vertical lines
extending from the top and bottom of each box denote the minimum
and maximum values within the data set located within an acceptable
range (points whose values is either greater than upper quartile ?1.5x
interquartile distance or less than lower quartile -1.5x interquartile
distance); outliers that are not included are represented by circles
b
Radiat Environ Biophys (2010) 49:27–37 33
123tumours, Rozalski et al. (2002) observed an about 50%
higher amount of 8-OHdG excreted into the urine, as
compared to healthy donors. It is generally accepted that
the products of the 8-OHdG repair are excreted into urine
without further metabolism (Suzuki et al. 1995). The
presence of 8-OHdG in urine is assumed to represent the
primary repair product of this oxidative DNA base damage
(Dianov et al. 1998). The higher 8-OHdG level in cancer
patients might be explained by a permanently increased
oxidative stress in their cells and/or by a decreased repair
of the oxidative DNA damage due to deﬁcient functioning
of the enzymes involved, e.g. hOGG1. Defective excision
of oxidative DNA damage was reported in malignant
prostate cancer cell lines (Fan et al. 2004). Reduced inci-
sion of 8-OHdG was associated with reduced hOGG1 2a
expression in mitochondrial extracts from prostate cancer
cell lines PC-3 and DU-145, as compared to wild-type
healthy cells (Trzeciak et al. 2004).
In ten patients (FISH analysis subgroup), also an
increased spontaneous rate of simple translocations was
found. This might reﬂect the same origin as in the case of
acentric fragments (oxidative DNA damage), since in the
process of damaged base excision secondary double-strand
breaks may be formed as well. Moreover, hydrogen per-
oxide originating from the superoxide anion radical, which
is produced permanently due to mitochondrial metabolism,
can induce double-strand-breaks directly.
Taken together, our ﬁndings point towards a deﬁciency
in primary antioxidative defence and/or a deﬁciency in the
repair or processing of oxidative DNA damage in cells
from patients with prostate cancer as a likely cause of the
increased spontaneous cytogenetic damage found in these
patients. The combined inﬂuence of other possible repair
defects might be also involved, as already pointed out by
Bristow et al. (2007) in their recent review on this topic.
Repair defects, especially in the oxidative damage repair,
in prostate cancer cells will be studied in a large patient
cohort. A deﬁcient coping with oxidative stress and/or
oxidative DNA damage in prostate cancer cells would be of
a valuable therapeutical signiﬁcance, allowing for new
combined chemo- and radiotherapy.
It has been argued that tumour burden might be a
potentially important confounding factor in the measure-
ment of DNA repair capacity in patients after tumour
diagnosis (Berwick and Vineis 2000). Tumour burden
might suppress or decrease DNA repair activity through
high metabolic rate and excessive endogenously generated
oxidative stress, which might affect lymphocytes and their
repair values (Pero et al. 1990). However, a recent study,
based on data of cancer incidence in the United States
Radiological Technologists Health Study (Sigurdson et al.
2003), reported on no evidence for differences in DNA
damage assessed before and after cancer diagnosis (Bhatti
et al. 2008b). Furthermore, family and classic twin studies
clearly indicated a genetic predisposition to mutagen sen-
sitivity (Klein et al. 2006; Roberts et al. 1999; Wu et al.
2006, 2007). In the present study, chromosome aberrations
were not affected by disease extension, as we found no
signiﬁcant differences between patients with prostate only
or with prostate and nodal disease.
In the follow-up part of our study (Fig. 3a–c), we
observed persisting rates of cytogenetic damage during the
ﬁrst year after radiotherapy. This is in contrast with ﬁndings
in patients with other types of cancer, e.g. testicular semi-
noma (Muller et al. 2005; Schmidberger et al. 2001) where
after 1 year post-therapy, the high rates of cytogenetic
damage observed shortly after therapy declined strongly.
Also in head-and-neck cancer patients, a strong decline of
cytogenetic damage rate by about 50% was observed in
patients’ blood lymphocytes (Xuncla et al. 2008).
The different results of the follow-up in prostate cancer
study might also reﬂect the involvement of oxidative stress
and its deﬁcient defence in these cells. Chronic oxidative
stress has already been associated with genomic/chromo-
somal instability following exposure to ionizing radiation
(Tulard et al. 2003). Dayal et al. (2008) reported recently
that in genomically unstable cells induced by ionizing
radiation, a threefold increase in steady-state levels of
hydrogen peroxide was observed. Their results clearly
demonstrated the causal relationship between persistent
oxidative stress induced by ionizing radiation via hydrogen
peroxide and genomically/chromosomally unstable cells
observed many generations after radiation exposure. The
increased rates of cytogenetic damage observed in patients’
lymphocytes 1 year after therapy might then reﬂect on
chromosomal instability induced in the bone marrow stem
cells repopulating the peripheral lymphocyte pool at that
time. A longer follow-up study is necessary to study the
prolonged presence of the cytogenetic damage in prostate
cancer patients and to possibly correlate late effects of
radiation therapy with the observed instability.
Our study has some limitations due to the small sample
size of the age-matched control group, and due to the small
number of patients followed up during radiation treatment
and 1 year afterwards. However, our main ﬁndings that
impaired DNA repair is at least not the only reason for
chromosomal instability before radiotherapy and that
instability persists after radiotherapy are strongly supported
by recent publications (Arsova-Saraﬁnovska et al. 2009;
Khandrika et al. 2009), which provide evidence for the
existence of imbalance in the oxidative stress/antioxidant
status in prostate cancer.
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